Suchergebnisse - "Salpini, Romina"

PubPharm (104)

41

Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report

enthalten in: Journal of medical case reports | 2019

von Foroghi Biland, L. | Ferrari, L. | Malagnino, V. | +8

42

New Markers in Monitoring the Reactivation of Hepatitis B Virus Infection in Immunocompromised Hosts

enthalten in: Viruses | 2019

von Svicher, V. | Salpini, R. | Malagnino, V. | +4

43

HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy

enthalten in: Scientific reports | 2019

von Malagnino, V. | Cerva, C. | Maffongelli, G. | +10

44

A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice : Evidence of a relevant risk of death and evolution from silent to chronic infection

enthalten in: Journal of viral hepatitis | 2019

von Salpini, R. | Battisti, A. | Colagrossi, L. | +18

45

Different Patterns of HIV-1 Replication in MACROPHAGES is Led by Co-Receptor Usage

enthalten in: Medicina (Kaunas, Lithuania) | 2019

von Borrajo, A. | Ranazzi, A. | Pollicita, M. | +7

46

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings : evidence from routine clinical practice in Cameroon

enthalten in: BMC infectious diseases | 2019

von Takou, D. | Fokam, J. | Teto, G. | +13

47

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

enthalten in: BMC infectious diseases | 2019

von Takou, D. | Fokam, J. | Teto, G. | +13

48

HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

enthalten in: BMC infectious diseases | 2019

von Takou, D. | Fokam, J. | Teto, G. | +13

49

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis

enthalten in: Open forum infectious diseases | 2019

von Ciardi, M. | Iannetta, M. | Zingaropoli, M. | +9

50

A snapshot of virological presentation and outcome of immunosuppression‐driven HBV reactivation from real clinical practice : Evidence of a relevant risk of death and evolution from silent to chronic infection

enthalten in: Journal of Viral Hepatitis | 2019

von Salpini, R. | Battisti, A. | Colagrossi, L. | +18